Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

mcr-1 and blaKPC-3 in Escherichia coli Sequence Type 744 after Meropenem and Colistin Therapy, Portugal.

Emerging infectious diseases - 1 Aug 2017

Tacão Marta, Tavares Rafael Dos Santos, Teixeira Pedro, Roxo Inês, Ramalheira Elmano, Ferreira Sónia, Henriques Isabel

Abstract excerpt

Escherichia coli Ec36 was recovered from a patient in Portugal after treatment with meropenem and colistin. Besides an IncF plasmid with Tn1441d-blaKPC-3, already reported in clinical strains in this country, E. coli Ec36 co-harbored an IncX4::mcr-1 gene. Results highlight emerging co-resistance to carbapenems and polymyxins after therapy with drugs from both classes.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta-Lactamases
Share to Colistin
Share to Drug Resistance, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Escherichia coli Infections

Share to Meropenem

Share to Portugal

Share to Serogroup

Share to Thienamycins

Source

Open in PubMed Open full text

Identifiers

PMID: 28726622
DOI: 10.3201/eid2308.170162
PMCID: PMC5547783

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

mcr-1 and blaKPC-3 in Escherichia coli Sequence Type 744 after Meropenem and Colistin Therapy, Portugal.PMID 28726622Read ↗

Co-occurrence of mcr-1 and blaKPC-2 in a clinical isolate of Escherichia coli in BrazilSemantic proximity Read ↗

Emergence of a multiresistant KPC-3 and VIM-1 carbapenemase-producing Escherichia coli strain in SpainSemantic proximity Read ↗

Within-host succession from an OXA-48-like to an NDM-type carbapenemase in clonal ST361 <i>Escherichia coli</i> recovered from sequential urinary and bloodstream infectionSemantic proximity Read ↗

mcr-1 in Carbapenemase-Producing Klebsiella pneumoniae with Hospitalized Patients, Portugal, 2016–2017Semantic proximity Read ↗

Evolution of ceftazidime-avibactam and cefiderocol resistance in ST131-H30R1- Escherichia coli isolates with KPC-3 mutants and application of FTIR biotypingSemantic proximity Read ↗

Co-existence of OXA-48 and NDM-1 in colistin resistant Pseudomonas aeruginosa ST235Semantic proximity Read ↗

New Variant of mcr-3 in an Extensively Drug-Resistant Escherichia coli Clinical Isolate Carrying mcr-1 and blaNDM-5.Semantic proximity Read ↗

Novel allelic variants of blaOXA-48-like carried on IncN2 and IncC2 plasmids isolated from clinical cases in Argentina: In vivo emergence of blaOXA-567.Semantic proximity Read ↗

Co-occurrence of mcr-9 and blaNDM-5 in Multidrug-Resistant Enterobacter hormaechei Strain Isolated from a Patient with Bloodstream InfectionSemantic proximity Read ↗

Outbreak of KPC-3-producing ST15 and ST348 Klebsiella pneumoniae in a Portuguese hospital.Semantic proximity Read ↗

First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria.Semantic proximity Read ↗

Coproduction of NDM-1 and KPC-2 in Enterobacter hormaechei from Brazil.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.